PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
122.53%
Net income growth above 1.5x AVGO's 9.27%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
2.13%
D&A growth well above AVGO's 1.51%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
75.61%
Well above AVGO's 113.95% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
12.07%
SBC growth well above AVGO's 16.20%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-63.77%
Both reduce yoy usage, with AVGO at -51.27%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-57.02%
Both yoy AR lines negative, with AVGO at -173.02%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-23.62%
Both reduce yoy inventory, with AVGO at -483.87%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-12.12%
Negative yoy AP while AVGO is 290.35%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-36.21%
Both reduce yoy usage, with AVGO at -311.11%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
712.50%
Growth of 712.50% while AVGO is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might reflect intangible expansions or partial write-offs.
148.91%
Operating cash flow growth above 1.5x AVGO's 4.61%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-18.75%
Negative yoy CapEx while AVGO is 0.39%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
11.84%
Less growth in investment purchases vs. AVGO's 100.00%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
-22.62%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-83.33%
We reduce yoy other investing while AVGO is 99.50%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-21.56%
We reduce yoy invests while AVGO stands at 47.67%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-44400.00%
Both yoy lines negative, with AVGO at -50.00%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
No Data
No Data available this quarter, please select a different quarter.
-222.22%
We cut yoy buybacks while AVGO is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.